HomeANEB • NASDAQ
add
Anebulo Pharmaceuticals Inc
Previous close
$1.04
Day range
$1.00 - $1.10
Year range
$0.80 - $3.08
Market cap
41.91M USD
Avg Volume
17.87K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.89M | 13.70% |
Net income | -1.68M | -1.37% |
Net profit margin | — | — |
Earnings per share | -0.04 | 33.33% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.28M | 158.01% |
Total assets | 14.01M | 133.64% |
Total liabilities | 546.03K | -45.95% |
Total equity | 13.46M | — |
Shares outstanding | 41.08M | — |
Price to book | 3.15 | — |
Return on assets | -31.70% | — |
Return on capital | -33.29% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.68M | -1.37% |
Cash from operations | -1.60M | -6.98% |
Cash from investing | — | — |
Cash from financing | -116.66K | — |
Net change in cash | -1.72M | -14.77% |
Free cash flow | -1.55M | -68.73% |
About
Founded
2020
Headquarters
Website
Employees
3
